.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
Argus Health
Medtronic
Merck
Cipla
QuintilesIMS
Cantor Fitzgerald
Daiichi Sankyo
US Department of Justice
Healthtrust

Generated: December 15, 2017

DrugPatentWatch Database Preview

Details for Patent: 6,319,192

« Back to Dashboard

Which drugs does patent 6,319,192 protect, and when does it expire?


Patent 6,319,192 protects CETROTIDE and is included in one NDA.

This patent has twenty-five patent family members in twenty-two countries.

Summary for Patent: 6,319,192

Title: Method for the treatment of fertility disorders
Abstract:An improvement to the method of intrauterine insemination by the administration of luteinizing hormone-releasing hormone antagonists (LHRH antagonists).
Inventor(s): Engel; Jurgen (Alzenau, DE), Riethmuller-Winzen; Hilde (Frankfurt, DE), Reissmann; Thomas (Frankfurt, DE)
Assignee: Zentaris AG (Frankfurt am Main, DE)
Application Number:09/296,610
Patent Claim Types:
see list of patent claims
Use;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Patented / Exclusive Use
Emd Serono IncCETROTIDEcetrorelixINJECTABLE;INJECTION021197-001Aug 11, 2000RXYesYes► Subscribe► Subscribe► SubscribePREVENTION OF PREMATURE LH SURGES IN WOMEN UNDERGOING CONTROLLED OVARIAN STIMULATION
Emd Serono IncCETROTIDEcetrorelixINJECTABLE;INJECTION021197-002Aug 11, 2000DISCNNoNo► Subscribe► Subscribe► SubscribePREVENTION OF PREMATURE LH SURGES IN WOMEN UNDERGOING CONTROLLED OVARIAN STIMULATION
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: 6,319,192

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Russian Federation2221588► Subscribe
Turkey200003063► Subscribe
Ukraine66850► Subscribe
Slovakia285192► Subscribe
Slovakia15302000► Subscribe
Slovenia1082129► Subscribe
Portugal1082129► Subscribe
Israel139027► Subscribe
Japan2002512975► Subscribe
Poland195989► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
Accenture
Daiichi Sankyo
Julphar
US Army
Harvard Business School
Teva
Deloitte
Chinese Patent Office
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot